Cargando…
Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood
INTRODUCTION: Late cardiotoxicity is a known complication of anthracycline therapy but the long-term effects of low cumulative doses are not well documented. We studied late cardiotoxicity in survivors of childhood acute lymphoblastic leukemia (ALL) treated with low anthracycline doses 10 to 20 year...
Autores principales: | Vandecruys, Els, Mondelaers, Veerle, De Wolf, Daniel, Benoit, Yves, Suys, Bert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279635/ https://www.ncbi.nlm.nih.gov/pubmed/21630046 http://dx.doi.org/10.1007/s11764-011-0186-6 |
Ejemplares similares
-
Early Detection of Anthracycline-Induced Cardiotoxicity in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Low Cumulative Dose
por: Salvo, Giovanni Di, et al.
Publicado: (2014) -
Evaluation of early-onset cardiotoxic effects of anthracyclines used during the treatment of childhood acute lymphoblastic leukemia by speckle-tracking echocardiography
por: Bilir, Özlem Arman, et al.
Publicado: (2021) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors
por: Sadurska, Elżbieta
Publicado: (2015) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)